Candel shares are moving lower on Friday after the company priced its $80 million underwritten public offering of shares and ...

Eco Wave Power Global ( (WAVE) ) has issued an update.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...

TD Cowen, Cantor, LifeSci Capital, Oppenheimer & Co. and Scotiabank acted as joint book-running managers of the offering.

Sacks Parente Golf, Inc. (NASDAQ: SPGC) (the "Company”), a technology-forward golf company with a growing portfolio of golf ...

Eyenovia, Inc. finalized a securities purchase agreement with an institutional investor for a registered direct offering. The agreement entailed the sale of 11,000,000 shares of common stock, ...

Candel Therapeutics (NASDAQ:CADL) priced an underwritten public offering of 10M shares at $6.00 per share and pre-funded ...

All of the shares and pre-funded warrants in the offering are to be sold by Revolution Medicines. In addition, Revolution Medicines has granted the underwriters a 30-day option to purchase up to an ...

at a public offering price of $63.00 per share and pre-funded warrants to purchase 238,095 shares of common stock at a price of $62.999 per pre-funded warrant, which represents the per share price ...

The revenue number in paragraph 5 was erroneously attributed to OpenReel instead of Banzai On Tuesday, Banzai International, ...